Atlas Trials

A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis

Clinical trial NCT01576887 · WITHDRAWN

Trial details

NCT number
NCT01576887
Sponsor
Biogen
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
End-Stage Renal DiseaseType 2 Diabetes Mellitus
Start date
2012-07-31
Primary completion
2012-10-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.